Trileptal (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Trileptal drug offered from Novartis Pharmaceuticals Corporation. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | oxcarbazepine |
SUBSTANCE NAME: | OXCARBAZEPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2000-01-30 |
END MARKETING DATE: | 0000-00-00 |
Trileptal HUMAN PRESCRIPTION DRUG Details:
Item Description | Trileptal from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2000-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0456_99a2ba76-61e7-4559-b029-c2158783eba8 |
PRODUCT NDC: | 0078-0456 |
APPLICATION NUMBER: | NDA021014 |
Other OXCARBAZEPINE Pharmaceutical Manufacturers / Labelers: